A Commonwealth Fund issue brief published last week reviewed state laws governing hospital financial assistance, billing and collections, and medical debt litigation, concluding that despite five years of accelerating legislative activity, significant gaps remain in standards, access, and enforcement. Medical debt affects an estimated three in 10 U.S. adults, the report notes.
The current landscape, per the report: 21 states (counting the District of Columbia) set minimum standards for hospital financial assistance, 14 states prohibit reporting medical debt to credit reporting agencies, 23 states bar wage garnishment and home liens or foreclosures to collect medical debt, and eight states require hospitals to screen patients for financial assistance or public insurance eligibility before advancing an account to collections.
The gaps the authors identify cut in multiple directions. Five of the 21 financial assistance states limit help to uninsured patients, and only 12 set income thresholds reaching patients earning below a living wage. Most protections stop at the hospital door, excluding ambulance services, physician and dental practices, and independently billing hospital-based clinicians. Delaware and Colorado are cited as exceptions with broader provider scope. Debt converted to a medical credit card generally sheds its protections entirely.
Enforcement is where the report finds the system thinnest. Nineteen states collect no compliance data at all, and only a handful, including Delaware and New Mexico, give patients a private right of action against hospitals or debt collectors. The authors argue that expanding private rights of action could offset finite public enforcement resources, a recommendation the industry will want to watch given the litigation exposure it would create.
The report also flags a frontier issue for the ARM industry: no state currently requires disclosure, validation, or oversight of AI and predictive analytics used in billing, eligibility screening, and collections workflows. The authors call this a regulatory blind spot, language that suggests where advocacy groups may push legislatures next.
The authors recommend states broaden eligibility and provider scope, reduce procedural burdens, and strengthen oversight. Translation for operators: expect more variation before there’s less.
